Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2025-12-25 @ 4:46 PM
NCT ID: NCT02060903
Description: None
Frequency Threshold: 5
Time Frame: Adverse events will be collected from the start of treatment until 14 days following IP treatment (approximately 15 days).
Study: NCT02060903
Study Brief: A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Abametapir Lotion 0.74% w/w Single topical treatment administered to hair and scalp for 10 minutes. Applied at home by a subject/caregiver. Abametapir Lotion 0.74% w/w 0 None 0 186 0 186 View
Vehicle Lotion Single topical treatment administered to hair and scalp for 10 minutes. Applied at home by a subject/caregiver. Vehicle Lotion 0 None 1 188 0 188 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Renal Impairment SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 10.0 View
Other Events(If Any):